OccuLogix, Inc.
NASDAQ : OCCX
TSX : OC

OccuLogix, Inc.

February 27, 2007 16:15 ET

OccuLogix to Present at Cowen and Company 27th Annual Health Care Conference

BOSTON, MASSACHUSETTS--(CCNMatthews - Feb. 27, 2007) - OccuLogix, Inc. (NASDAQ:OCCX)(TSX:OC) announced today that it will present at the Cowen and Company 27th Annual Health Care Conference at the The Boston Marriott Copley Place Hotel in Boston, MA on Tuesday, March 13 at 9:30 AM Eastern Time.

A webcast of OccuLogix's presentation will be available live and archived at the Investor Relations section of www.occulogix.com.

About OccuLogix, Inc.

OccuLogix is building a leading company focused on ophthalmic devices for the diagnosis and treatment of age-related eye diseases. Visit us on the internet at www.occulogix.com (corporate). Additional information on the Company's RHEO™ procedure to treat Dry AMD can be found at www.rheo.com. To learn more about the Company's SOLX® Gold Shunt and SOLX® 790 Laser for the treatment of glaucoma, please visit www.solx.com.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the Company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian securities regulatory authorities, including but not limited to our Forms 10-K and 10-Q. We do not undertake to update any forward-looking statements.

Contact Information